Proteins Linked To Congenital Deafness Help Build,
Maintain Inner Ear Stereocilia
Editor: It seems to me that the more scientists discover about how we
hear and what can go wrong, the more complex the issue becomes. Here's the
latest report on work being conducted by the folks at the National
Institute on Deafness and Other Communication Disorders (NIDCD).
~~~~~~~~~~~~~~~~~
March 2009
If the inner ear were a city, then stereocilia could be considered the
flashy, high-rise buildings making up the skyline. Protruding from the
tops of sensory cells, called hair cells, inside the inner ear,
stereocilia are composed of long filaments of actin, a robust protein that
also assists in muscle contraction, cell division, and other cellular
activities. They are also the site at which sound vibrations entering the
ear are converted into electrical signals that travel to the brain, so
scientists want to know more about how stereocilia are constructed.
Researchers from the National Institute on Deafness and Other
Communication Disorders (NIDCD), one of the National Institutes of Health,
and others have now learned that two proteins that have been implicated in
some forms of inherited deafness are responsible for building and
maintaining these exquisitely formed structures. The research is published
in the March 15, 2009, Advance Online Publication of Nature Cell Biology.
Stereocilia are arranged in tiered bundles, with one bundle topping
each hair cell. Tiny filaments connect the shorter stereocilia to their
taller neighbors so that, when stimulated by sound, the entire hair bundle
moves as a unit. Moreover, each hair bundle is fine-tuned to respond to a
specific sound frequency, with the length of its projections correlated to
its preferred pitch. The lower the pitch, the longer the stereocilia need
to be; the higher the pitch, the shorter the stereocilia.
In earlier studies, NIDCD scientist Bechara Kachar, M.D., and others
found that, throughout our lives, our stereociliia operate like constantly
moving treadmills in which new actin is added to the tip of the filament
and older actin is pushed downward until it reaches the bottom, at which
point it can be recycled and added to the tip again. Exactly how the
stereocilia are assembled remained unclear, however.
Using immunofluroescence techniques, Dr. Kachar and others in NIDCD's
Laboratory of Cell Structure and Dynamics, along with researchers at the
University of Maryland, University of North Carolina, and University of
California, Berkeley, found that myosin IIIa and espin 1 co-localize at
the tips of the stereocilia. However, they noted that the two proteins
were present in a more graded fashion along the length of the stereocilium,
with the highest concentration at the tip. This indicated that the two
proteins are continuously climbing from the bottom to the tip as opposed
to being stationed there permanently.
When the researchers coaxed hair cells, as well as other non-sensory
cells, to express more of the two proteins through the insertion of DNA,
the filaments grew longer than they did when only one of the two proteins
was added.
Based on these and other confirming biochemical and molecular biology
techniques, the scientists concluded that myosin IIIa transports espin 1
from the base of the stereocilium to the tip, where espin 1 begins its
task of adding more actin to the filament. Myosin IIIa is a "motor
protein," a protein that burns energy to move materials within cells.
Although individual actin monomers-the bricks, so to speak-are smaller and
can diffuse up the stereocilia on their own, espin 1- the machinery
required to lay the bricks-is much larger and requires a lift to the top.
Once the stereocilia reach their required height, the length is
dynamically maintained.
Dr. Kachar likens the scenario to a home builder who suddenly decides
to build a skyscraper instead. The builder would need a whole new set of
tools and equipment to do that. So these two molecules, which are the
products of genes whose mutations result in deafness, seem to be involved
in the mechanism to build and maintain high-rises.
Dr. Kachar points out that, although a mutation in the gene that
produces espin 1 results in hearing loss in newborns, mutations in the
gene that produces myosin IIIa cause late-onset deafness, which can begin
when a person reaches his or her 20s. This raises a new question: If
myosin IIIa is so important to building and maintaining stereocilia, why
isn't the hearing loss immediate? His team is currently studying whether a
similar myosin present in stereocilia-myosin IIIb-compensates for the lack
of myosin IIIa before a person reaches early adulthood. These and other
findings could enable researchers to consider new tools for replacing or
compensating for defective proteins, thus opening up additional
opportunities for the development of therapeutic strategies for hearing
loss.